Skip to main content

Briacell Therapeutics Corp(BCT-T)
TSX

Today's Change
Real-Time Last Update
Day Low6.81
Day High6.81
Open:6.81
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
AI-generated - The Globe and Mail
Closing Bell: Briacell Therapeutics Corp down on Wednesday (BCT)
AI-generated - The Globe and Mail
Closing Bell: Briacell Therapeutics Corp up on Monday (BCT)
AI-generated - The Globe and Mail
Closing Bell: Briacell Therapeutics Corp down on Friday (BCT)
AI-generated - The Globe and Mail
Closing Bell: Briacell Therapeutics Corp down on Thursday (BCT)
AI-generated - The Globe and Mail
Closing Bell: Briacell Therapeutics Corp down on Wednesday (BCT)
AI-generated - The Globe and Mail
Closing Bell: Briacell Therapeutics Corp down on Tuesday (BCT)
AI-generated - The Globe and Mail
Closing Bell: Briacell Therapeutics Corp down on Monday (BCT)
AI-generated - The Globe and Mail
Closing Bell: Briacell Therapeutics Corp down on Friday (BCT)
AI-generated - The Globe and Mail
Closing Bell: Briacell Therapeutics Corp up on Thursday (BCT)
AI-generated - The Globe and Mail
Closing Bell: Briacell Therapeutics Corp down on Wednesday (BCT)
AI-generated - The Globe and Mail
Closing Bell: Briacell Therapeutics Corp flat on Tuesday (BCT)
AI-generated - The Globe and Mail
Closing Bell: Briacell Therapeutics Corp up on Monday (BCT)
AI-generated - The Globe and Mail
Closing Bell: Briacell Therapeutics Corp down on Friday (BCT)
AI-generated - The Globe and Mail
Closing Bell: Briacell Therapeutics Corp down on Thursday (BCT)
AI-generated - The Globe and Mail
Closing Bell: Briacell Therapeutics Corp up on Wednesday (BCT)
AI-generated - The Globe and Mail
Closing Bell: Briacell Therapeutics Corp down on Tuesday (BCT)
AI-generated - The Globe and Mail
Closing Bell: Briacell Therapeutics Corp down on Friday (BCT)
AI-generated - The Globe and Mail
Closing Bell: Briacell Therapeutics Corp down on Friday (BCT)
AI-generated - The Globe and Mail
Closing Bell: Briacell Therapeutics Corp up on Thursday (BCT)
AI-generated - The Globe and Mail
Closing Bell: Briacell Therapeutics Corp down on Wednesday (BCT)
AI-generated - The Globe and Mail
Closing Bell: Briacell Therapeutics Corp down on Tuesday (BCT)
AI-generated - The Globe and Mail
Closing Bell: Briacell Therapeutics Corp down on Monday (BCT)
AI-generated - The Globe and Mail
Closing Bell: Briacell Therapeutics Corp up on Friday (BCT)
AI-generated - The Globe and Mail
Closing Bell: Briacell Therapeutics Corp up on Thursday (BCT)
AI-generated - The Globe and Mail
Closing Bell: Briacell Therapeutics Corp up on Wednesday (BCT)
AI-generated - The Globe and Mail
Closing Bell: Briacell Therapeutics Corp up on Tuesday (BCT)
AI-generated - The Globe and Mail
Closing Bell: Briacell Therapeutics Corp flat on Monday (BCT)
AI-generated - The Globe and Mail
Closing Bell: Briacell Therapeutics Corp down on Friday (BCT)
AI-generated - The Globe and Mail
Closing Bell: Briacell Therapeutics Corp down on Thursday (BCT)
AI-generated - The Globe and Mail
Closing Bell: Briacell Therapeutics Corp up on Wednesday (BCT)
AI-generated - The Globe and Mail
Closing Bell: Briacell Therapeutics Corp down on Tuesday (BCT)
AI-generated - The Globe and Mail
Closing Bell: Briacell Therapeutics Corp down on Monday (BCT)

Profile

BriaCell Therapeutics Corp is an immuno-oncology-focused biotechnology company. The group develops targeted and safe approaches for the management of cancer. BriaCell is conducting a Phase I/IIa clinical trial of Bria-IMT in metastatic breast cancer. Additionally, it is developing Bria-OTS, off-the-shelf personalized immunotherapy, for the treatment of advance-stage breast cancer by matching the patient's HLA type.